Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pain Therapeutics PTIE

"Pain Therapeutics Inc is a biopharmaceutical company that develops novel drugs. The Company has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma."


NDAQ:PTIE - Post by User

Post by ezcostelloon Sep 07, 2016 12:15pm
244 Views
Post# 25214125

Charles Brandes

Charles BrandesCharles Brandes, a world top billionaire increased his position in Pain by 300% this year. Doesn't that tell you anything folks? 

"During the first quarter the investor increased his stake by 107.92% and increased it 108.80% in the second quarter. The investor holds 0.17% of outstanding shares in the stock, a biopharmaceutical company that develops novel drugs. The company has four drug candidates in clinical programs including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma."

https://en.wikipedia.org/wiki/Charles_Brandes



<< Previous
Bullboard Posts
Next >>